Siddiqi, Najma

The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness

Firth, J., Siddiqi, N., Koyanagi, A., Siskind, D., Rosenbaum, S., Galletly, C., Allan, S., Caneo, C., Carney, R., Carvalho, A. F., et al. (2019) · The Lancet Psychiatry

Mental Health Treatment and AccessPsychiatric care and mental health services

Cited by 1,531

Interventions for preventing delirium in hospitalised non-ICU patients

Siddiqi, N., Harrison, J. K., Clegg, A., Teale, E. A., Young, J., Taylor, J., & Simpkins, S. A. (2016) · Cochrane Database of Systematic Reviews

Intensive Care Unit Cognitive DisordersDementia and Cognitive Impairment Research

Cited by 619

Antipsychotics for treatment of delirium in hospitalised non-ICU patients

Burry, L., Mehta, S., Perreault, M. M., Luxenberg, J. S., Siddiqi, N., Hutton, B., Fergusson, D. A., Bell, C., & Rose, L. (2018) · Cochrane Database of Systematic Reviews

Intensive Care Unit Cognitive DisordersAlcoholism and Thiamine Deficiency

Cited by 237

Interventions for preventing delirium in older people in institutional long-term care

Clegg, A., Siddiqi, N., Heaven, A., Young, J., & Holt, R. (2014) · Cochrane Database of Systematic Reviews

Intensive Care Unit Cognitive DisordersGeriatric Care and Nursing Homes

Cited by 100

Association between depression and smoking: a global perspective from 48 low- and middle-income countries

Stubbs, B., Vancampfort, D., Firth, J., Solmi, M., Siddiqi, N., Smith, L., Carvalho, A. F., & Koyanagi, A. (2018) · Journal of Psychiatric Research

Smoking Behavior and CessationMental Health Treatment and Access

Cited by 82

Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial

McAllister-Williams, R. H., Anderson, I. M., Finkelmeyer, A., Gallagher, P., Grunze, H. C. R., Haddad, P. M., Hughes, T., Lloyd, A. J., Mamasoula, C., McColl, E., et al. (2016) · The Lancet Psychiatry

Treatment of Major DepressionStress Responses and Cortisol

Cited by 47

Behavioural activation therapy for depression in adults with non-communicable diseases

Uphoff, E., Pires, M., Barbui, C., Barua, D., Churchill, R., Cristofalo, D., Ekers, D., Fottrell, E., Mazumdar, P., Purgato, M., et al. (2020) · Cochrane Database of Systematic Reviews

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychotherapy Techniques and Applications

Cited by 33

Efficacy of a culturally adapted, cognitive behavioural therapy-based intervention for postnatal depression in British south Asian women (ROSHNI 2): a multicentre, randomised controlled trial

Husain, N., Lunat, F., Lovell, K., Miah, J., Chew-Graham, C. A., Bee, P., Waqas, A., Pierce, M., Sharma, D., Atif, N., et al. (2024) · The Lancet

Maternal Mental Health During Pregnancy and PostpartumMaternal and Neonatal Healthcare

Cited by 27

The prevalence of diabetes mellitus and abnormal glucose metabolism in the inpatient psychiatric setting: a systematic review and meta-analysis

Roberts, E., Jones, L., Blackman, A., Dewhurst, T., Matcham, F., Kan, C., Mustafa, O., Thomas, T., Siddiqi, N., Ismail, K., et al. (2017) · General Hospital Psychiatry

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 23

A randomised controlled feasibility trial of Behavioural activation as a treatment for people with diabetes and depression: (DiaDeM feasibility trial)

Ahmed, N., Zavala, G. A., Siddiqui, F., Aslam, F., Keding, A., Halmkan, S., Afaq, S., Jennings, H. M., Anas, A., Shaha, S. K., et al. (2025) · Journal of Affective Disorders

Diabetes Management and EducationAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 6